Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

402 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Nomenclature of HBV core protein-targeting antivirals.
Zoulim F, Zlotnick A, Buchholz S, Donaldson E, Fry J, Gaggar A, Hu J, Kann M, Lenz O, Lin K, Mani N, Nassal M, Delaney W, Wang S, Westman G, Miller V, Janssen HLA. Zoulim F, et al. Among authors: donaldson e. Nat Rev Gastroenterol Hepatol. 2022 Dec;19(12):748-750. doi: 10.1038/s41575-022-00700-z. Nat Rev Gastroenterol Hepatol. 2022. PMID: 36207612 Free PMC article. No abstract available.
Association Between Seroclearance of Hepatitis B Surface Antigen and Long-term Clinical Outcomes of Patients With Chronic Hepatitis B Virus Infection: Systematic Review and Meta-analysis.
Anderson RT, Choi HSJ, Lenz O, Peters MG, Janssen HLA, Mishra P, Donaldson E, Westman G, Buchholz S, Miller V, Hansen BE. Anderson RT, et al. Among authors: donaldson e. Clin Gastroenterol Hepatol. 2021 Mar;19(3):463-472. doi: 10.1016/j.cgh.2020.05.041. Epub 2020 May 27. Clin Gastroenterol Hepatol. 2021. PMID: 32473348
Immunological biomarker discovery in cure regimens for chronic hepatitis B virus infection.
Gehring AJ, Mendez P, Richter K, Ertl H, Donaldson EF, Mishra P, Maini M, Boonstra A, Lauer G, de Creus A, Whitaker K, Martinez SF, Weber J, Gainor E, Miller V. Gehring AJ, et al. Among authors: donaldson ef. J Hepatol. 2022 Aug;77(2):525-538. doi: 10.1016/j.jhep.2022.02.020. Epub 2022 Mar 5. J Hepatol. 2022. PMID: 35259469 Free article. Review.
FDA perspective on sofosbuvir therapy for patients with chronic hepatitis C virus genotype 1 infection who did not respond to treatment with pegylated interferon and ribavirin.
Mishra P, Florian J, Qi K, Zeng W, Naeger LK, Donaldson E, Connelly S, O'Rear J, Price D, Murray J, Birnkrant D. Mishra P, et al. Among authors: donaldson e. Gastroenterology. 2014 Dec;147(6):1196-200. doi: 10.1053/j.gastro.2014.10.027. Epub 2014 Oct 27. Gastroenterology. 2014. PMID: 25449024 No abstract available.
Benefit-risk assessment for brincidofovir for the treatment of smallpox: U.S. Food and Drug Administration's Evaluation.
Chan-Tack K, Harrington P, Bensman T, Choi SY, Donaldson E, O'Rear J, McMillan D, Myers L, Seaton M, Ghantous H, Cao Y, Valappil T, Birnkrant D, Struble K. Chan-Tack K, et al. Among authors: donaldson e. Antiviral Res. 2021 Nov;195:105182. doi: 10.1016/j.antiviral.2021.105182. Epub 2021 Sep 25. Antiviral Res. 2021. PMID: 34582915 Review.
402 results